BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24201596)

  • 1. Residual neuromuscular block in type II diabetes mellitus after rocuronium: a prospective observational study.
    Armendáriz-Buil I; Lobato-Solores F; Aguilera-Celorrio L; Morros-Díaz E; Fraile-Jiménez E; Vera-Bella J
    Eur J Anaesthesiol; 2014 Aug; 31(8):411-6. PubMed ID: 24201596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
    Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
    Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
    Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
    Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified TOF-ratio to assess rocuronium-induced neuromuscular block: a comparison with the usual TOF-ratio.
    Schmartz D; Bernard P; Sghaier R; Fils JF; Fuchs-Buder T
    Anaesth Crit Care Pain Med; 2022 Aug; 41(4):101088. PubMed ID: 35489709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study.
    Saager L; Maiese EM; Bash LD; Meyer TA; Minkowitz H; Groudine S; Philip BK; Tanaka P; Gan TJ; Rodriguez-Blanco Y; Soto R; Heisel O
    J Clin Anesth; 2019 Aug; 55():33-41. PubMed ID: 30594097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extremely prolonged neuromuscular block after a single dose of rocuronium].
    Menouni O; Brillouet-Banchereau AC; Galan G; Lélias A; Sautereau A; Gadrey S
    Ann Fr Anesth Reanim; 2011 Nov; 30(11):841-3. PubMed ID: 21983058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of intense neuromuscular blockade caused by rocuronium using posttetanic count in male and female patients.
    Baykara N; Sahin T; Alpar R; Solak M; Toker K
    J Clin Anesth; 2003 Sep; 15(6):446-50. PubMed ID: 14652123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equi-lasting doses of rocuronium, compared to mivacurium, result in improved neuromuscular blockade in patients undergoing gynecological laparoscopy : [Des doses de durée équivalente de rocuronium, comparé au mivacurium, améliorent la curarisation chez des patientes qui subissent une laparoscopie gynécologique].
    Dahaba AA; Schweitzer E; Fitzgerald RD; Schwarz S
    Can J Anaesth; 2001 Dec; 48(11):1084-90. PubMed ID: 11744584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
    Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
    Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of the use of neuromuscular transmission monitoring on immediate postoperative extubation in off-pump coronary artery bypass surgery.
    Cammu G; De Keersmaecker K; Casselman F; Coddens J; Hendrickx J; Van Praet E; Deloof T
    Eur J Anaesthesiol; 2003 Nov; 20(11):884-90. PubMed ID: 14649340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of different sugammadex doses on the train of four ratio recovery progression during rocuronium induced neuromuscular blockade in the rat phrenic nerve hemidiaphragm.
    Kim YB; Choi JM; Chang YJ; Choi HR; In J; Yang HS
    Korean J Anesthesiol; 2020 Jun; 73(3):239-246. PubMed ID: 31619027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparison Between the Adductor Pollicis Muscle Using TOF-Watch SX and the Abductor Digiti Minimi Muscle Using TetraGraph in Rocuronium-Induced Neuromuscular Block: A Prospective Observational Study.
    Iwasaki H; Yamamoto M; Sato H; Doshu-Kajiura A; Kitajima O; Takagi S; Luthe SK; Suzuki T
    Anesth Analg; 2022 Aug; 135(2):370-375. PubMed ID: 35061641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of age on maintenance of intense neuromuscular block with rocuronium.
    Furuya T; Suzuki T; Kashiwai A; Konishi J; Aono M; Hirose N; Kato J; Ogawa S
    Acta Anaesthesiol Scand; 2012 Feb; 56(2):236-9. PubMed ID: 22236347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adamgammadex in patients to reverse a moderate rocuronium-induced neuromuscular block.
    Jiang YY; Zhang YJ; Zhu ZQ; Huang YD; Zhou DC; Liu JC; Li CY; Liu J; Liu B; Zhang WS
    Br J Clin Pharmacol; 2022 Aug; 88(8):3760-3770. PubMed ID: 35304924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of sugammadex (Org 25969) in reversing moderate neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
    Takeda J; Iwasaki H; Yamakage M; Ozaki M; Kawamata M; Hatano Y; Yorozuya T; Miyakawa H; Kanmura Y
    Masui; 2014 Oct; 63(10):1075-82. PubMed ID: 25693332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
    de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
    Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
    Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
    Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
    Abdulatif M; Mowafi H; al-Ghamdi A; el-Sanabary M
    Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.